B‐cell modulation with anti‐CD79b antibodies ameliorates experimental autoimmune encephalitis in mice-Reference-Cited by-同舟云学术

B‐cell modulation with anti‐CD79b antibodies ameliorates experimental autoimmune encephalitis in mice

Published:2022-01-11 Issue: Volume: Page:
ISSN:0014-2980
Container-title:European Journal of Immunology
language:en
Short-container-title:Eur J Immunol

Author:

Renner Kerstin¹,Neumayer Sophia¹,Talke Yvonne¹,Buchtler Simone¹,Schmidbauer Kathrin¹,Nimmerjahn Falk²^ORCID,Lux Anja²,Winter Frederike¹³,Salewski Jan‐Nicklas¹,Mack Matthias¹³

Affiliation:

1. Department of Internal Medicine II—Nephrology University Hospital Regensburg Regensburg Germany

2. Division of Genetics Department of Biology University Erlangen‐Nuernberg Erlangen Germany

3. Regensburg Center for Interventional Immunology Regensburg Germany

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/eji.202149523

Reference43 articles.

1. Multiple sclerosis;Noseworthy J. H.;N Engl J Med,2000

2. The evidence for a role of B cells in multiple sclerosis;Disanto G.;Neurology,2012

3. Targeting B cells in the treatment of multiple sclerosis: recent advances and remaining challenges;Lehmann‐Horn K.;Ther Adv Neurol Disord,2013

4. Cooperation of B cells and T cells in the pathogenesis of multiple sclerosis;Weber M. S.;Results Probl Cell Differ,2010

5. Rituximab in patients with primary progressive multiple sclerosis: results of a randomized double‐blind placebo‐controlled multicenter trial;Hawker K.;Ann Neurol,2009

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Disseminated tuberculosis after Polatuzumab‐Vedotin based chemoimmunotherapy in a patient with Burkitt's lymphoma;Clinical Case Reports;2024-05